FindTrial
Sign In

Willow bark extract for acute pulpal pain patients

to assesss and compare the efficacy of willow bark extract with ibuprofen for patients with acute pulpal pain -a randomized placebo controlled double blinded clinical trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082204
Enrollment
150
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services Health Condition 2: K040- Pulpitis

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patient who are willing to participate in the study. (2) Patients of age between 16 and 45 years. (3) Patients with Dental caries with Acute pulpal pain.

Exclusion criteria

Exclusion criteria: (1)History of any allergic reaction to herbal preparations. (2) Pregnancy & Lactating women (3)Patients with gastric irritation and any other systemic illness and undergoing treatment for the same. (4) Patients with other orofacial pain and swelling. (5) Patients with involvement of acute pulpal pain in multiple teeth.

Design outcomes

Primary

MeasureTime frame
assess efficacy of Willow bark extract and compare with ibubrufenTimepoint: pain score noted after 6 hours—

Secondary

MeasureTime frame
compare the efficacy of willow bark to that of ibuprofenTimepoint: at the end of 2nd month—

Countries

India

Contacts

Public ContactBVINU PRIYA

SRM

vinupriyab8@gmail.com9677322827

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026